Publication:
New-Onset Primary Adrenal Insufficiency After COVID-19: Case Report

dc.authorscopusid59325103000
dc.authorscopusid59325641700
dc.authorscopusid55537171600
dc.authorscopusid13407057000
dc.authorscopusid8572843800
dc.contributor.authorKayhan, Y.
dc.contributor.authorAzizova, L.
dc.contributor.authorKan, E. K.
dc.contributor.authorAtmaca, Ayşegül
dc.contributor.authorColak, R.
dc.contributor.authorIDAzizova, Leyla/0000-0001-7785-2058
dc.date.accessioned2025-12-11T00:52:40Z
dc.date.issued2024
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Kayhan, Y.; Azizova, L.; Kan, E. K.; Atmaca, A.; Colak, R.] Ondokuz Mayis Univ, Fac Med Endocrinol & Metab, Samsun, Turkiyeen_US
dc.descriptionAzizova, Leyla/0000-0001-7785-2058en_US
dc.description.abstractCOVID-19 primarily affects the respiratory system. What comes after the disease is now a greater concern for the scientific world. It is remarkable for causing endocrine organ involvement, particularly in the adrenal glands. However, its effect on the adrenal gland has not been fully elucidated. A case of primary adrenal insufficiency after COVID-19. A 31-year-old female patient who presented with complaints of weakness, anorexia, nausea, recent onset of vomiting, dizziness, and low blood pressure for two months was admitted to the outpatient Department of Endocrinology and Metabolism. After discharge, the patient had routine follow-ups, and here we present the information on the first and seventh month after discharge. The patient was diagnosed with primary adrenal insufficiency with cortisol <0.054 <mu>g/dL and adrenocorticotropic hormone >1200 pg/mL in the laboratory. In the non-contrast computed tomography taken in the adrenal protocol, the stem and leaves of both adrenal glands are significantly thinned and appear atrophic, the right adrenal gland is hardly distinguished. Hydrocortisone was started. All complaints were resolved within a week, except hyperpigmentation, which was resolved six months later after treatment. Our study support adrenal gland involvement due to COVID-19, further research is needed to obtain data on damage mechanisms.en_US
dc.description.woscitationindexScience Citation Index Expanded
dc.identifier.doi10.4183/aeb.2024.90
dc.identifier.endpage92en_US
dc.identifier.issn1841-0987
dc.identifier.issn1843-066X
dc.identifier.issue1en_US
dc.identifier.pmid39372307
dc.identifier.scopus2-s2.0-85205263458
dc.identifier.scopusqualityQ4
dc.identifier.startpage90en_US
dc.identifier.urihttps://doi.org/10.4183/aeb.2024.90
dc.identifier.urihttps://hdl.handle.net/20.500.12712/39902
dc.identifier.volume20en_US
dc.identifier.wosWOS:001338532900014
dc.identifier.wosqualityQ4
dc.language.isoenen_US
dc.publisherEditura Acad Romaneen_US
dc.relation.ispartofActa Endocrinologica-Bucharesten_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectPrimary Adrenal Insufficiencyen_US
dc.subjectCOVID-19en_US
dc.titleNew-Onset Primary Adrenal Insufficiency After COVID-19: Case Reporten_US
dc.typeArticleen_US
dspace.entity.typePublication

Files